NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.
about
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsCreation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.The future potential for cocaine vaccines.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesVaccine targets against Moraxella catarrhalis.Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model.Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.Current strategies in immunotherapy for acute myeloid leukemia.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugsNew generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells.CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses.Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine.
P2860
Q27012618-E1C5212B-4CE7-44EB-A8A4-60AB4DCE2EA7Q33553918-89C6EE6E-59A5-4D66-B35A-CCA3192AD0EEQ34132804-43217935-AEF9-4197-AEBB-06B41C730E92Q35738486-4E5A19EF-02E5-42A0-8DC9-5D9D54453AE6Q36483998-EA5F1EFA-497F-401C-9F7A-8C687BE5FA48Q37254491-36755CE0-2604-4C4E-9627-F1C903904C99Q37489033-B7140707-7D93-451A-A61F-1AAA499199ADQ38068967-1D276847-53F3-415C-A612-E1478244CEA8Q38206520-AA3661C3-082D-42F2-A30B-220D178FF00CQ38245928-1FC06F24-9A9C-4A5A-A167-5C0D87368FAFQ38773109-00858B09-4648-457E-905E-A7F8CEA93151Q38990679-BC264F59-6548-4A2C-B73B-32E62E48D945Q39079690-AA741D88-B690-45FE-9C2A-209FB3652C1EQ42723974-C58A5E24-BD0E-454B-89FE-5D52BF778600Q49900917-F6F8E1D3-B583-45EC-991D-C68CEA1D39B8Q53415023-4AE155D2-4493-4B5D-93F6-BF34C3922063
P2860
NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
NOD/scid IL-2Rg
@nl
NOD/scid IL-2Rg(null) mice: a ...... ed vaccine strategies in vivo.
@en
type
label
NOD/scid IL-2Rg
@nl
NOD/scid IL-2Rg(null) mice: a ...... ed vaccine strategies in vivo.
@en
prefLabel
NOD/scid IL-2Rg
@nl
NOD/scid IL-2Rg(null) mice: a ...... ed vaccine strategies in vivo.
@en
P2093
P2860
P356
P1476
NOD/scid IL-2Rg(null) mice: a ...... ed vaccine strategies in vivo.
@en
P2093
Bernhard Frankenberger
Dolores J Schendel
Stefani Spranger
P2860
P2888
P356
10.1186/1479-5876-10-30
P577
2012-02-25T00:00:00Z
P5875
P6179
1048360417